|
PRESS RELEASE
October 15, 2008
Academic Medicine
Means Business for
Ohio:
$37.2 billion
economic impact for
the state
(ATHENS) — Ohio’s
academic health care
industry, which
includes the Ohio
University College
of Osteopathic
Medicine, plays a
major role in the
state’s economy and
serves as a major
job generator,
according to an
independent study
commissioned by the
Ohio Council of
Medical School
Deans.
According to the
report, OU-COM had a
$5.9 billion impact
on the Ohio economy,
while generating
more than $196
million in state
revenue. The medical
college and its
affiliated teaching
hospitals across the
state supported the
equivalent of 48,141
jobs,
according to report.
Quantifying academic
medicine’s economic
impact in
areas ranging from
tax revenue to job
creation, the
report underscores
the significant role
Ohio’s seven medical
colleges and
affiliated teaching
hospitals play in
spurring growth as
the state works to
transform its
economy.
“Our medical
school’s research
has led to the
development of new
drugs and diagnostic
tests, which in turn
has produced new
companies; and that
has created jobs for
Ohioans,” said Jack
Brose, D.O., dean of
OU-COM and chair of
the Council of
Medical school Deans
from 2004 to 2007.
“Medical education
is about creating
physicians and
providing care for
the community, but
if you look at the
numbers, we’re a
critical part of the
state’s economy, as
well”
At OU-COM, research
has led to a number
of
revenue-generating
technologies and
companies, and more
licensed
technologies are
expected in the
future, Brose said.
Ohio University
earned $9.3 million
in licensing
royalties
in the past
two
for the
drug Somavert.
Marketed by
Pfizer for people
with acromegaly, a
form of gigantism
that creates
excessive growth of
bones and organs in
adults, Somavert was
a 1988 research
discovery by OU-HCOM
faculty member and
eminent scholar John
Kopchick, Ph.D.
About 90 percent of
Ohio University
research royalties
stem from Somavert
licensing fees. Income
generated by
Somavert is
reinvested in
research at all
levels of the
university—the
inventor’s
department, the
inventor’s college
and the university
generally. OU-HCOM
received about $1.4
million from
Somavert royalties,
Dean Jack Brose,
D.O., reported.
Forbes
magazine recently
ranked Ohio
University fourth in
the country for the
amount of licensing
revenues it
generates in
relation to its
research funding.
The Forbes
study was
on 2006
data from the
Association of
University
Technology Managers
(AUTM). The
university had a 13
percent return on
investment,
according to
Forbes’
findings.
In addition to
Somavert, research
generated at OU-COM
contributed to three
locally based
companies, including
Interthyr, DiAthegen,
and Diagnostic
Hybrids Inc., the
latter of which
employs several
hundred workers at
its East State
Street facility in
Athens. To further
develop and
commercialize
research at the
college, OU-COM is a
central partner in a
new 92,000 square
foot, $34 million
Academic Research
Center. Slated to
open in winter 2010,
the building will
provide lab space
for the development
of new medical
technologies,
techniques and
pharmaceuticals that
will lead to new
revenue streams for
the college and
university.
OU-COM also
contributes to the
state economy by
graduating a large
number of physicians
who remain in the
state to practice
medicine, and by
bringing
out-of-state medical
students, interns
and residents into
Ohio.
“OU-COM consistently
has more of its
graduates practicing
in Ohio than any
other medical
school,” Brose said.
“Every one of these
medical practices
can be considered a
small business.”
Of all OU-COM
graduates, 62
percent remain in
Ohio to practice
medicine. About 11
percent of all
OU-COM graduates
practice in
Appalachia Ohio,
contributing to the
regional economy and
providing care to
underserved
communities.
In addition to the
15 to 20
out-of-state
students who
annually matriculate
to OU-COM, more than
100 students from
out-of-state medical
schools enter the
Centers for
Osteopathic Research
and Education system
annually for their
clinical training.
Not only do more
than 50 percent of
OU-COM’s graduates
choose CORE
hospitals for their
residencies and
internships, but
graduates from other
medical schools from
across the nation
choose a CORE
hospital for their
graduate education
as well. As a
result, OU-COM
imports -- and often
retains -- talent in
Ohio.
Other findings
include the
following:
Ohio’s seven medical
colleges attracted
nearly 66% of the
$628 million in
highly competitive,
National Institutes
of Health research
funding awarded to
Ohio researchers in
2007, according to
the study.
-
Ohio’s
academic
health
care
industry
is
one
of
Ohio’s
lead
generators
of
employment—with
425,000
full-time
positions,
meaning
one
in
every
12
workers
in
Ohio
works
directly
or
indirectly
for
a
medical
school
or
teaching
hospital,
according
to
the
study.
-
Medical
school
graduates
who
remain
within
the
state
after
graduation
to
practice
medicine
represent
an
additional
impact
of
nearly
$700
million
annually,
according
to
the
study.
“Mission-driven
medicine is a
win-win for Ohio,”
notes David Stern, M.D., current chair of the Council, vice president for
health affairs at
the University of
Cincinnati and dean
of UC’s College of
Medicine.
“This report
demonstrates that
our patient care,
teaching and
research missions
have a significant
impact on commerce,
investment, taxes
and employment in
the state.”
Founded in 1993, the
Ohio Council of
Medical Deans
represents Ohio’s
seven medical
colleges and
teaching hospitals
including
Ohio University
College of
Osteopathic
Medicine, Case
Western Reserve
University School of
Medicine, University
of Cincinnati
College of Medicine,
Northeastern Ohio
Universities
Colleges of Medicine
and Pharmacy, The
Ohio State
University College
of Medicine, The
University of Toledo
College of Medicine
and Wright State
University Boonshoft
School of Medicine.
The report was
produced by Tripp
Umbach, which has
conducted economic
impact studies for
hundreds of health
care institutions
and medical colleges
throughout the
country.
|